Kimera

The startup manufactures the eCG hormone, used to stimulate estrus and ovulation in cows and gilts for artificial insemination, through recombinant protein expression techniques. The marketed hormone has a lower production cost than its competitors and does not inflict suffering to animals, compared to the traditional approaches used.

BUSINESS MODEL: B2B and B2C

PRODUCT: Complete

STAGE: Commercial approval

For further information, please contact us.

Back to Investors page